A Trial of HR19042 Capsule in Healthy Chinese Subjects

NCT04887532 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary IgA Nephropathy

Interventions

DRUG: HR19042 capsule

Sponsor

Jiangsu HengRui Medicine Co., Ltd.